NIH recommends against anti-malaria drug/antibiotic combination for coronavirus - press
- Pres Trump had promoted the combination treatment
- The guidelines for treatment being developed by NIH consider two categories of therapies used by healthcare providers for COVID-19: antivirals and host modifiers, and immune based therapies